This site is intended for healthcare professionals
Insight

New rare disease platform launched for Hunter Syndrome

Read time: 1 mins
Last updated:1st Feb 2018
Published:1st Feb 2018
Source: Pharmawand

Hunter syndrome (MPS II) is a rare condition resulting from mutations in the gene that codes for the production of the lysosomal enzyme iduronate-2-sulfatase (I2S). Recognition and diagnosis at an early stage is crucial to establishing appropriate management strategies.

Read more in the Hunter Syndrome Knowledge Centre.

Please note the Hunter Syndrome Knowledge Centre is not intended for HCPs in USA or UK. It has been developed by EPG Health for Medthority.com, in collaboration with Shire.  

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.